transform + with calcium
transform + with calcium, licence 80039227: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Genuine Health Inc.
- NPN or DIN-HM
- 80039227
- Status
- Inactive licence
- Licence date
- 28 January 2013
- Revision date
- Not provided
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Contains tea (Camellia sinensis). Green tea extracts must provide less than 800 mg of epigallocatechin-3-gallate per daily portion, with mandatory warnings.
annexe III, partie B (règlement (UE) 2022/2340). Regulation (EC) No 1925/2006, latest consolidated version, retrieved 21 October 2026.
- Conditions légales
Glycine max. (L.) Merr.: La portion journalière recommandée ne doit pas conduire à une ingestion d'isoflavones supérieure à 1 mg/kg de poids corporel (exprimés comme aglycone du composant principal). L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Camellia sinensis (L.) Kuntze: Seules sont admises la poudre issue du broyage des feuilles et les préparations obtenues à partir des solvants suivants : l'eau, l'alcool à 25 % (v/v), ainsi que les solvants autorisés pour la décaféination ou la suppression des matières irritantes et amères. Les recommandations d'emploi ne doivent pas conduire à une ingestion quotidienne d'EGCG supérieure à 300 mg. L'étiquetage doit comporter des avertissements déconseillant leur prise en dehors des repas, ainsi que leur consommation par les enfants, les adolescents, les femmes enceintes ou allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Isolat de protéine de soja Source : Glycine max, Fève soja Potency : 6.2 mg ÉAI Soy isoflavones | 5.0 g | Not calculated |
| Lactobacillus rhamnosus Source : Isolated from dehydrated milk (R0011) | 0.215 Milliards d'UFC | Not calculated |
| Bifidobacterium bifidum Source : Isolated from human adult intestine (R0071) | 0.02 Milliards d'UFC | Not calculated |
| Bifidobacterium breve Source : Isolated from infant intestine (R0070) | 0.012 Milliards d'UFC | Not calculated |
| Lithothamnion corallioides Source : Algues Potency : 34.0 % Calcium | 781.25 mg | Not calculated |
| Lactobacillus plantarum Source : Isolated from vegetable source (R1012) | 0.045 Milliards d'UFC | Not calculated |
| Oryza sativa Source : Kernel | 191.5 mg | Not calculated |
| Glycine max Source : Germe(s) | 191.5 mg | Not calculated |
| Fructo-oligosaccharides Source : Chicory Root (Cichorium intybus) | 50.0 mg | Not calculated |
| 1,3-bêta-D-xylane xylanohydrolase Source : Trichoderma longibrachiatum Potency : 205.0 XU | 15.0 mg | Not calculated |
| Camellia sinensis Source : Feuille Extraction ratio : 20:1 Dry plant equivalent : 150 mg Potency : 90.0 % Polyphenols | 7.5 mg | Not calculated |
| Vitis vinifera Source : Raisin Potency : 0.0 200ppm/.02% Reservatrol | Not specified | Not calculated |
| Beta vulgaris Source : Racine | 21.5 mg | Not calculated |
| Ginkgo biloba Source : Feuille Extraction ratio : 50:1 Dry plant equivalent : 500 mg Potency : 24.0 % Gingko flavonglycosides | 10.0 mg | Not calculated |
| Chlorella pyrenoidosa Source : Cracked cell wall | 191.5 mg | Not calculated |
| Triacylglycérol lipase Source : Aspergillus niger Potency : 518.0 FCC LU | 15.0 mg | Not calculated |
Non-medicinal ingredients
Chlorure de sodium, Stevia, acide malique, Saveur d'orange naturelle, Saveur de vanille naturelle, Malt extract, Dioxyde de silicium, Réglisse séchée, Acide citrique, Saveur de tangerine naturelle
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2.0 Mesures | minimum: 1.0 Tous les jours ; maximum: 2.0 Tous les jours |
Uses authorised in Canada
Excellent source of whey and soy protein isolates for general health, restoring of amino acid levels, and a source of phytochemical-rich greens+ for increased energy. Helps in the development and maintenance of bones and teeth. Calcium intake, when combined with sufficient vitamin D, a healthy diet, and regular exercise, may reduce the risk of developing osteoporosis. Source of antioxidants to reduce oxidative stress/damage for the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
If you have diabetes, consult a health care practitioner prior to use. If you have gastrointestinal lesion/ulcer are taking an anticoagulant/blood thinner or an anti-inflammatory, or are having surgery, consult a health care practitioner prior to use. Consult a health care practitioner prior to use if you have nausea, fever, vomiting, bloody diarrhoea or severe abdominal pain. Consult a healthcare practitioner prior to use if you have a liver disorder or develop liver-related symptoms (e.g. abdominal pain, jaundice, dark urine). Consult a healthcare practitioner prior to use if you are taking thyroid hormone replacement therapy.
Source
Official Health Canada record, licence 80039227
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
Has the product changed? Photograph the packaging.